Cheaper cancer drug alternative under Real-World scrutiny
Disease control
Recruiting now
This study is tracking how well a biosimilar drug called Elovie (a copy of bevacizumab) works for people with advanced colorectal cancer that cannot be removed by surgery. Researchers will follow 133 patients in Brazil who are receiving Elovie as their first treatment, measuring …
Sponsor: Libbs Farmacêutica LTDA • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC